The engagement that started in 2005 is one of the longest running strategic partnerships for HCL globally and includes delivery of whole range of services including transformational software led IT solutions, infrastructure management, business and knowledge process services.
“HCL shares our vision of making a difference to people’s lives by providing leading innovations and solutions for tomorrow,” said Clark Golestani, Executive Vice President and CIO, Merck & Co. “HCL’s commitment and deep IT expertise have been critical in our journey towards a successful technology-enabled enterprise.This engagement is a collaborative relationship that has resulted in excellent business outcomes for both companies.”
HCL has been a key partner in helping Merck accelerate R&D and cost optimization through integrated application and infrastructure management. HCL continues to work with Merck, leveraging its cross industry expertise in Digital, Mobility and Big Data Analytics to drive business agility and growth. In the Digital Domain, HCL is creating a unique collaborative framework where end-users engage more closely with the design and development team and accelerate time to market.
“We are proud to be associated with Merck & Co. The last 10 years have been a rewarding journey with Merck & Co. It is exciting to see this relationship grow beyond the contract and where we have been able to deliver unique value consistently,” said Sandeep Kishore, Corporate Vice President, Life Sciences Healthcare and Public Services HCL Technologies. “Our relationship with Merck has played a key role in HCL’s evolution as an integrated service provider and leader in Life Sciences and Healthcare space.”
HCL is a dominant Life Sciences player enjoying market leadership position in the Life Sciences and Medical Devices segment for North America. HCL clientele consists of the top global pharmaceutical companies, medical devices companies, health plans, CRO’s and data providers. Equipped with certified technology experts and domain specialists, HCL offers services in critical areas of the life sciences and healthcare eco system such as drug discovery, clinical development, drug safety, regulatory compliance, manufacturing and plant automation, commercial, Healthcare analytics, Population Health Management [PHM], mHealth, member experience management [MEM], fraud, waste and abuse management [FWA].
About HCL Technologies
HCL Technologies (hcltech.com) is a leading global IT services company working with clients in the areas that impact and redefine the core of their businesses. Since its emergence on global landscape after its IPO in 1999, HCL has focused on 'transformational outsourcing', underlined by innovation and value creation, offering an integrated portfolio of services including software-led IT solutions, remote infrastructure management, engineering and R&D services and Business services. HCL leverages its extensive global offshore infrastructure and network of offices in 31 countries to provide holistic, multi-service delivery in key industry verticals including Financial Services, Manufacturing, Consumer Services, Public Services and Healthcare & Life sciences. HCL’s organizational beliefs of 'Employees First, Customers Second', ‘Trust, Transparency and Flexibility’, and ‘Value Centricity’ empower its 104,184 Ideapreneurs to create real value for customers by delivering a Relationship Beyond the Contract. HCL Technologies, along with its subsidiaries, had consolidated revenues of US$ 5.8 billion, as on 31st March 2015 (on LTM basis).
HCL Forward-looking Statements
Certain statements in this release are forward-looking statements, which involve a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ materially from those in such forward-looking statements. All statements, other than statements of historical fact are statements that could be deemed forward looking statements, including but not limited to the statements containing the words 'planned','expects','believes’, ’ strategy','opportunity','anticipates','hopes' or other similar words. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding impact of pending regulatory proceedings, fluctuations in earnings, our ability to manage growth, intense competition in IT services, Business Process Outsourcing and consulting services including those factors which may affect our cost advantage, wage increases in India, customer acceptances of our services, products and fee structures, our ability to attract and retain highly skilled professionals, our ability to integrate acquired assets in a cost effective and timely manner, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, the success of our brand development efforts, liability for damages on our service contracts, the success of the companies /entities in which we have made strategic investments, withdrawal of governmental fiscal incentives, political instability, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property, other risks, uncertainties and general economic conditions affecting our industry. There can be no assurance that the forward looking statements made herein will prove to be accurate, and issuance of such forward looking statements should not be regarded as a representation by the Company, or any other person, that the objective and plans of the Company will be achieved. All forward looking statements made herein are based on information presently available to the management of the Company and the Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.